Scientific Program

The program consists of the following session topics:

• Session I: Burden of RSV Disease and Mortality
• Session II: COVID-19 Impact on RSV Development
• Session III: RSV Immunology
• Session IV: RSV Clinical Interventions (incl. Vaccines, mAbs & Antivirals)
• Session V: Latest Developments in RSV Molecular Virology 
• Session VI: Combating RSV: LMICs' Perspectives

Watch the video below for a tutorial of the conference platform.

Go to conference platform

​Scientific Program

​Abstract Booklet 

Pre-Symposiums

Resvinet supports Young Researchers

---

ReSViNET ambition is to keep encouraging young and emerging researchers. Some of the best and most innovative ideas come from young scientists, and their research is essential for continued innovation in the RSV field. ReSViNET is proud to have organised the RSVVW’21 edition of the Young Researchers’ Tournament, for exceptional and innovative research in the RSV field.

Benefits of an online virtual conference

NO RISKS

​Join the conference from the comfort of your own home! This means no health or financial risks.

EASY NETWORKING

Using live text and video chat, you can engage with experts and get their personalized insights about the topics of the conference.

ACCESSIBILITY

You will have access to the conference material before, during and at least 3 months after the event!

RSVVW'21 was organized by

Organizing Committee

---

​Louis Bont
​ReSViNET Board of Directors, Wilhelmina Children’s Hospital, University Medical Center Utrecht
Utrecht, The Netherlands





​Deborah Higgins
RSV Vaccine Project at PATH
Seattle, Washington, United States
​
​



Harish Nair
Paediatric Infectious Diseases & Global Health, University of Edinburgh
Edinburgh, United Kingdom



​
​
​Peter Richmond
Faculty of Health & Medical Sciences, Paediatrics, University of Western Australia
Perth, Australia

Leyla Kragten-Tabatabaie
ReSViNET Board of Directors, Julius Clinical
Zeist, The Netherlands





Sophie Mazur
ReSViNET Foundation
Zeist, The Netherlands

​

​
​
​
Roxie van Lieshout
​ReSViNET Foundation
Zeist, The Netherlands

Scientific Advisory Committee

---

Barney Graham
Viral Pathogenesis Laboratory & Translational Science Core & National Institute of Allergy & Infectious Diseases 
Bethesda, United States






Cheryl Cohen
Associate Professor of Epidemiology, University of the Witwatersrand
Johannesburg, South Africa


​

Terho Heikkinen
Professor of Paediatrics, Specialist in Paediatric Infectious Diseases
Turku, Finland





Naveen Thacker
Deep Children Hospital & Research Centre
Gandhidham, India






Linda Eckert
Professor of Global Health, Professor of Obstetrics & Gynecology, University of Washington
Seattle, Washington, United States




​
​
Patrick Munywoki 
Centers for Disease Control & Prevention
Nairobi, Kenya

Keith Klugman
Pneumonia Program, Bill & Melinda Gates Foundation (BMGF) 
Seattle, Washington, United States





Asuncion Meijas
Associate Professor of Pediatrics, Nationwide Children’s Hospital and The Ohio State University 
Columbus, Ohio, USA





Fernando Polack
Department of Pediatrics at Vanderbilt University, Director of the INFANT Foundation
Buenos Aires, Argentina




​
Yvette Löwensteyn
PhD Candidate RSV Research Group, Wilhelmina Children's Hospital
Utrecht, The Netherlands
​
​



Lawrence Mwananyanda
Research Assistant Professor, Global Health, Boston University 
​Lusaka, Zambia 

RSVVW'21 Sponsors